12:00 AM
 | 
Oct 07, 2013
 |  BC Week In Review  |  Company News  |  Other News

GlaxoSmithKline, Columbia University, New York University pharmaceuticals news

As of Sept. 20, five research proposals requesting patient-level data from GlaxoSmithKline under the pharma's January open access initiative have been approved. No request has been rejected. The four remaining submitted proposals are either being checked for compliance or are under review by an independent panel.

In April, Perry Nisen,...

Read the full 233 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >